Full history for every metric is available with a Kvantra account
Cutera, Inc. (CUTR)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 163 | 182 | 148 | 231 | 252 | 212 | 155 |
| Operating profit | $m | -156 | -131 | |||||
| Net profit | $m | -31 | -12 | -24 | 2 | -82 | -163 | -132 |
| EPS reported | $ | -8.19 | -6.58 | |||||
| Operating cashflow per share | $ | -6.93 | -6.93 | |||||
| Capex per share | $ | 1.66 | 1.66 | |||||
| FCF per share | $ | -8.59 | -8.59 | |||||
| Free cash flow | $m | -171 | -120 | |||||
| Net debt | $m | 275 | 363 | |||||
| Book value equity | $m | -172 | -253 | |||||
| Book value per share | $ | -8.64 | -12.55 | |||||
| Number of shares | m | 19.89 | 20.15 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.41 | -0.01 | |||||
| P/S LTM | x | 0.33 | 0.01 | |||||
| P/FCF LTM | x | -0.41 | -0.02 | |||||
| EV/EBITDA LTM | x | -2.54 | -3.46 | |||||
| EV/Sales LTM | x | 1.69 | 2.35 | |||||
| Earnings Yield LTM | % | -231.98% | -8450.7% | |||||
| FCF Yield | % | -243.44% | -6154.3% | |||||
| Quality | ||||||||
| ROE | % | 94.76% | 174.14% | |||||
| ROIC | % | -59.67% | -59.67% | |||||
| Operating margin | % | -73.57% | -73.57% | |||||
| Gross margin | % | 19.54% | 19.54% | |||||
| FCF/Sales | % | -80.46% | -80.46% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -15.86% | -32.53% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.40 | -0.28 | |||||
| Net Debt/EBITDA | x | -2.05 | -2.05 | |||||
| EBIT/Net interest | x | -11.15 | -11.15 | |||||
| Net debt/market cap | % | 391.89% | 18548.3% | |||||
| Net debt/Equity | x | -1.60 | -1.43 | |||||
| Gross debt/equity | x | -2.51 | -1.71 | |||||
Company overview
Cutera, Inc. is a medical technology enterprise specializing in the research, development, manufacturing, marketing, and servicing of cutting-edge laser and energy-based aesthetic systems for medical professionals worldwide. The company's comprehensive product line includes several advanced devices: Secret PRO, an innovative system combining fractional CO2 technology for thorough skin resurfacing with radio frequency (RF) microneedling for deep dermal tissue restructuring. truSculpt flex, a bio-electrical muscle stimulation apparatus engineered to support individuals across all fitness capabilities. excel V+, a versatile platform designed for addressing vascular and benign pigmented lesions. truSculpt iD, specifically tailored for the non-invasive body contouring sector. Secret RF, a fractional RF microneedling system that promotes precise tissue coagulation and hemostasis. Cutera also provides robust multi-application platforms: The enlighten platform, a laser system highly effective for tattoo removal, as well as treating benign pigmented lesions and acne scarring. The excel HR platform, offering an extensive hair removal solution compatible with diverse skin types. The xeo platform, a adaptable system where users can acquire various handpiece attachments to manage unwanted hair, treat vascular lesions, and achieve overall skin revitalization by targeting discoloration, fine lines, and laxity. In addition to its device offerings, Cutera distributes a range of skincare products and delivers post-warranty support, accessible via extended service agreements or direct billing. The company supplies specialized pulsed light handpieces for treating discoloration, facilitating hair removal, and managing vascular conditions. It further offers Pearl and Pearl Fractional handpieces, along with essential consumables such as handpiece refills, cycle refills, consumable tips, and marketing materials, all available for purchase through its official website. Cutera's products are marketed and sold through a direct sales team, reaching a wide spectrum of medical and aesthetic professionals. This includes plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, other certified practitioners, and even medical doctors performing aesthetic procedures in non-clinical environments. Founded in 1988, Cutera, Inc. maintains its corporate headquarters in Brisbane, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Cutera, Inc. (CUTR)
Cutera, Inc. is a medical technology enterprise specializing in the research, development, manufacturing, marketing, and servicing of cutting-edge laser and energy-based aesthetic systems for medical professionals worldwide. The company's comprehensive product line includes several advanced devices: Secret PRO, an innovative system combining fractional CO2 technology for thorough skin resurfacing with radio frequency (RF) microneedling for deep dermal tissue restructuring. truSculpt flex, a bio-electrical muscle stimulation apparatus engineered to support individuals across all fitness capabilities. excel V+, a versatile platform designed for addressing vascular and benign pigmented lesions. truSculpt iD, specifically tailored for the non-invasive body contouring sector. Secret RF, a fractional RF microneedling system that promotes precise tissue coagulation and hemostasis. Cutera also provides robust multi-application platforms: The enlighten platform, a laser system highly effective for tattoo removal, as well as treating benign pigmented lesions and acne scarring. The excel HR platform, offering an extensive hair removal solution compatible with diverse skin types. The xeo platform, a adaptable system where users can acquire various handpiece attachments to manage unwanted hair, treat vascular lesions, and achieve overall skin revitalization by targeting discoloration, fine lines, and laxity. In addition to its device offerings, Cutera distributes a range of skincare products and delivers post-warranty support, accessible via extended service agreements or direct billing. The company supplies specialized pulsed light handpieces for treating discoloration, facilitating hair removal, and managing vascular conditions. It further offers Pearl and Pearl Fractional handpieces, along with essential consumables such as handpiece refills, cycle refills, consumable tips, and marketing materials, all available for purchase through its official website. Cutera's products are marketed and sold through a direct sales team, reaching a wide spectrum of medical and aesthetic professionals. This includes plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, other certified practitioners, and even medical doctors performing aesthetic procedures in non-clinical environments. Founded in 1988, Cutera, Inc. maintains its corporate headquarters in Brisbane, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free